Skip to main content
Premium Trial:

Request an Annual Quote

ETH Zurich Licenses DNAStar's Lasergene for Sequence Analysis

Premium

DNAStar said this week that the Swiss Federal Institute of Technology, or ETH, Zurich has selected its Lasergene software for sequence analysis.

The financial terms of the license agreement were not disclosed.

The Lasergene DNA and protein sequence analysis software is comprised of eight applications including tools for sequence assembly and SNP detection, automated virtual cloning, and primer design.

Other institutions that have licensed the product for their genomic analysis projects this year include Monash University (BI 12/2/2011) and the University of Texas (BI 11/11/2011).

The ETH Zurich agreement is the first European deal disclosed since the company this summer terminated a 15-year agreement that authorized GATC Biotech to distribute Lasergene in several European countries, opting instead to market its products directly to customers in those markets (BI 7/22/2011).

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.